MYLIP anticorps (Internal Region)
Aperçu rapide pour MYLIP anticorps (Internal Region) (ABIN6257336)
Antigène
Voir toutes MYLIP AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Internal Region
-
Specificité
- MYLIP Antibody detects endogenous levels of total MYLIP.
-
Homologie
- Pig,Bovine,Horse,Rabbit,Dog,Chicken,Xenopus
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogène
- A synthesized peptide derived from human MYLIP, corresponding to a region within the internal amino acids.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:1000, IHC: 1:50-1:200, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C. Stable for 12 months from date of receipt.
-
Date de péremption
- 12 months
-
-
- MYLIP (Myosin Regulatory Light Chain Interacting Protein (MYLIP))
-
Autre désignation
- MYLIP
-
Sujet
-
Description: E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of myosin regulatory light chain (MRLC), LDLR, VLDLR and LRP8. Activity depends on E2 enzymes of the UBE2D family. Proteasomal degradation of MRLC leads to inhibit neurite outgrowth in presence of NGF by counteracting the stabilization of MRLC by saposin-like protein (CNPY2/MSAP) and reducing CNPY2-stimulated neurite outgrowth. Acts as a sterol-dependent inhibitor of cellular cholesterol uptake by mediating ubiquitination and subsequent degradation of LDLR.
Gene: MYLIP
-
Poids moléculaire
- 50 kDa
-
ID gène
- 29116
-
UniProt
- Q8WY64
Antigène
-